España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Evogene
EVGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.80
-0.01
-0.55%
Pre-Market: 9:25 AM EDT
Get Report
Comment
Evogene (EVGN) Forecast
News
Earnings
Evogene (EVGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Evogene (NASDAQ:EVGN) Stock
Evogene Stock (NASDAQ: EVGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 21, 2024
Evogene Q3 2024 GAAP EPS $(1.31) Misses $(0.6...
Benzinga Newsdesk
Earnings Scheduled For November 21, 2024
Benzinga Insights
Wednesday, November 20, 2024
A Glimpse of Evogene's Earnings Potential
Benzinga Insights
Tuesday, November 19, 2024
Evogene Subsidiary Lavie Bio's LAV321 Bio-Fun...
Benzinga Newsdesk
Thursday, October 31, 2024
Evogene shares are trading higher after the c...
Benzinga Newsdesk
Evogene Announces Collaboration With Google C...
Benzinga Newsdesk
Tuesday, October 08, 2024
Watershed and Evogene Receive Grant to Advanc...
Benzinga Newsdesk
Monday, September 30, 2024
Evogene shares are trading higher after the c...
Benzinga Newsdesk
Lavie Bio, A Subsidiary Of Evogene Received A...
Benzinga Newsdesk
Friday, August 23, 2024
Lake Street Maintains Buy on Evogene, Lowers ...
Benzinga Newsdesk
Evogene Prices $5.5M Registered Direct Offeri...
Benzinga Newsdesk
Thursday, August 22, 2024
Evogene shares are trading lower after the co...
Benzinga Newsdesk
Evogene Q2 2024 GAAP EPS $(1.06) May Not Be C...
Benzinga Newsdesk
Wednesday, July 24, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, July 23, 2024
Evogene shares are trading lower after the co...
Benzinga Newsdesk
Reported Earlier, Evogene Announces 1-for-10 ...
Benzinga Newsdesk
Wednesday, July 17, 2024
ICL And Lavie Bio Leverage AI To Make Signifi...
Benzinga Newsdesk
Tuesday, July 02, 2024
Lavie Bio Expands Yalos Bio-Inoculant to Wint...
Benzinga Newsdesk
Tuesday, June 25, 2024
Evogene Subsidiary Casterra Ag Expands into A...
Benzinga Newsdesk
Thursday, May 23, 2024
Biomica Announces Encouraging Initial Finding...
Benzinga Newsdesk
Evogene Q1 2024 GAAP EPS $(0.08) Beats $(0.09...
Benzinga Newsdesk
Thursday, March 07, 2024
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Jelena Martinovic
Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
Evogene Earnings Preview
Benzinga Insights
AgPlenus Achieves Milestone In Collaboration ...
Benzinga Newsdesk
Tuesday, March 05, 2024
Casterra Announced New Agreements With Seed Producers in Brazil And Africa To Meet Growing Demand ForIts Elite Castor Seed Varieties
Charles Gross
Tuesday, February 20, 2024
Syngenta and Evogene Ltd Subsidiary, Lavie Bi...
Benzinga Newsdesk
Tuesday, February 06, 2024
Evogene and Verb Biotics Enter Collaboration ...
Benzinga Newsdesk
Thursday, November 16, 2023
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
Patricio Liddle
Wednesday, November 15, 2023
Earnings Scheduled For November 15, 2023
Benzinga Insights
Recap: Evogene Q3 Earnings
Benzinga Insights
Evogene Q3 EPS $(0.08) Vs $(0.16) YoY, Sales ...
Benzinga Newsdesk
Tuesday, November 14, 2023
A Preview Of Evogene's Earnings
Benzinga Insights
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
Benzinga Insights
Alliance Global Partners Initiates Coverage O...
Benzinga Newsdesk
Wednesday, September 27, 2023
Casterra Delivers First Shipment of Castor Se...
Benzinga Newsdesk
Thursday, September 21, 2023
Why Evogene Shares Are Moving
Henry Khederian
Evogene shares are trading lower after the co...
Benzinga Newsdesk
Evogene Reports Receipt of Nasdaq Minimum Bid...
Benzinga Newsdesk
Thursday, September 14, 2023
Evogene Receives Notice Of Allowance For U.S....
Benzinga Newsdesk
Friday, August 18, 2023
Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
Benzinga Insights
Lake Street Maintains Buy on Evogene, Raises ...
Benzinga Newsdesk
Thursday, August 17, 2023
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
Jelena Martinovic
Evogene Q2 EPS $(0.17), Inline, Sales $654.00...
Benzinga Newsdesk
Wednesday, August 16, 2023
Earnings Outlook For Evogene
Benzinga Insights
Friday, July 21, 2023
Roth MKM Maintains Buy on Evogene, Raises Pri...
Benzinga Newsdesk
Monday, July 17, 2023
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Evogene Stock Is Tanking Today
Vuk Zdinjak
Show More
